Quanterix Corp (NAS:QTRX)
$ 11.06 -0.01 (-0.09%) Market Cap: 426.08 Mil Enterprise Value: 169.82 Mil PE Ratio: 0 PB Ratio: 1.26 GF Score: 71/100

Quanterix Corp at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 02:45PM GMT
Release Date Price: $24.05 (+3.40%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

All right. Good morning, everybody. Good morning. My name is Luke Sergott. I cover life science tools and diagnostics. I have with me Kevin Hrusovsky and Masoud Toloue of Quanterix. Kind of get your names right.

E. Kevin Hrusovsky
Quanterix Corporation - Chairman & CEO

That was pretty good, Luke.

Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

It was pretty close. There's a lot of confidence there leading off. So I guess you guys want to go over a couple of slides here if you want to go over and then we'll dig into some Q&A.

E. Kevin Hrusovsky
Quanterix Corporation - Chairman & CEO

Yes. So maybe just to start off, if much of -- just from the standpoint of Quanterix, it's really great to be here first, Luke. And I do think that this is a very pivotal moment for our company. We're at a very important, inflection point given the Lilly deal that we were

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot